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ORIGINAL ARTICLEEpiplakin Is a Paraneoplastic Pemphigus
Autoantigen and Related to Bronchiolitis
Obliterans in Japanese Patients
Atsunari Tsuchisaka1, Sanae Numata1, Kwesi Teye1, Yohei Natsuaki1, Tamihiro Kawakami2,
Yoshito Takeda3, Wenqing Wang4, Kazushi Ishikawa4, Mizuki Goto4, Hiroshi Koga1, Ryosuke Sogame1,
Norito Ishii1, Shinzo Takamori5, Tomoaki Hoshino6, Oliver Brandt7, Hendri H. Pas8, Sakuhei Fujiwara4
and Takashi Hashimoto1All plakin family proteins are known to be autoantigens in paraneoplastic pemphigus (PNP). In this study, we
first examined whether PNP sera also react with epiplakin, another plakin protein, by various immunological
methods using 48 Japanese PNP sera. Immunofluorescence confirmed that cultured keratinocytes expressed
epiplakin. Epiplakin was detected by 72.9% of PNP sera by immunoprecipitation-immunoblotting with KU-8 cell
extract, but not by immunoblotting of either normal human epidermal extract or KU-8 cell extract. Epiplakin
was essentially not detected by 95 disease and normal control sera. Statistical analyses of various clinical and
immunological findings revealed a significant correlation of the presence of anti-epiplakin antibodies with both
bronchiolitis obliterans and mortality. No epiplakin-negative PNP case developed bronchiolitis obliterans.
However, although 29.4% of European patients with PNP had bronchiolitis obliterans, significant correlation
with anti-epiplakin autoantibodies was not observed. In further studies for lung, immunofluorescence showed
the presence of epiplakin in normal human lung, particularly respiratory bronchiole, immunoprecipitation-
immunoblotting showed that PNP sera reacted with epiplakin in cultured lung cells, and mice injected with
polyclonal antibody specific to epiplakin histopathologically showed abnormal changes in small airway
epithelia. These results indicated that epiplakin is one of the major PNP autoantigens and is related to PNP-
related bronchiolitis obliterans.
Journal of Investigative Dermatology (2016) 136, 399e408; doi:10.1038/JID.2015.408INTRODUCTION
Paraneoplastic pemphigus (PNP), or paraneoplastic autoim-
mune multiorgan syndrome (Nguyen et al., 2001), is an
autoimmune blistering skin disease with severe mucocuta-
neous lesions. PNP is commonly associated with1Department of Dermatology, Kurume University School of Medicine, and
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Abbreviations: BO, bronchiolitis obliterans; BP, bullous pemphigoid; Dsg,
desmoglein; EPL, envoplakin; EPPK, epiplakin; IB, immunoblotting; IF,
immunofluorescence; IHC, immunohistochemistry; IP, immunoprecipitation;
NHSAE, normal human small airway epithelial; pAb, polyclonal antibody;
PNP, paraneoplastic pemphigus; PPL, periplakin; RP, recombinant protein
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1990). Histopathology shows acantholysis and apoptotic
cells in epidermis and interface changes (Anhalt, 1997;
Anhalt et al., 1990; Billet et al., 2006; Sehgal et al., 2009).
Prognosis of PNP is poor with approximately 68% mor-
tality (Leger et al., 2012). Particularly, all PNP cases with
chronic respiratory disease show fatal outcome (Nousari
et al., 1999; Takahashi et al., 2000). Severe inflammation
occurring in respiratory bronchioles leads to irreversible
fibrotic reaction, resembling bronchiolitis obliterans (BO). In
a previous study, BO occurred in 6% of 53 European patients
with PNP (Leger et al., 2012), whereas the prevalence was
25% in our recent study for 107 Japanese patients with PNP.
However, pathogenesis in PNP-related BO is currently
unknown.
PNP develops autoantibodies to various antigens, mainly
plakin family proteins. Immunoprecipitation (IP) first detected
the 250-kDa desmoplakin I, the 230-kDa bullous pemphi-
goid 230 (BP230), the 210-kDa doublet of desmoplakin II
and unknown protein, and the 190-kDa and 170-kDa un-
known proteins (Anhalt et al., 1990). Then, immunoblotting
(IB) of normal human epidermal extract showed that all PNP
sera reacted with the 210-kDa and 190-kDa doublet proteins
(Borradori et al., 1998; Hashimoto, 2001; Hashimoto et al.,
1995). Thereafter, the 210-kDa and 190-kDa proteins were
identified as envoplakin (EPL) and periplakin (PPL), respec-
tively (Kiyokawa et al., 1998). This reactivity is very useful forestigative Dermatology. www.jidonline.org 399
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400diagnosis of PNP (Joly et al., 2000; Mouquet et al., 2008; Poot
et al., 2013). Plectin, another plakin protein, was also found
to be PNP autoantigen (Proby et al., 1999). Thus, all known
plakin proteins are PNP autoantigens.
Non-plakin proteins are also detected by PNP sera. ELISAs
detected antibodies to desmoglein 3 (Dsg3) and/or Dsg1 in
PNP sera (Amagai et al., 1998; Brandt et al., 2012). We also
found that the unknown 170-kDa protein was alpha-2-
macroglobulin-like-1 (Numata et al., 2013; Schepens et al.,
2010), and BP180 was frequently reacted by PNP sera
(Tsuchisaka et al., 2014).
Epiplakin (EPPK) was originally identified as an auto-
antigen in a patient (Fujiwara et al., 1996), and is expressed
in entire epidermis, skin appendices, and other intestinal
epithelia (Fujiwara et al., 2001). Subsequent studies showed
that EPPK is a plakin protein with many repeats of plakin-
specific B-domain and linker-domain (Spazierer et al.,
2003; Takeo et al., 2003). EPPK connects intermediate fila-
ments (Spazierer et al., 2006, 2008; Wang et al., 2006).
Despite abundant expression of EPPK in stratified and simple
epithelia, gene-targeted mice showed no abnormality in
either phenotype or keratin filament organization, except for
mild delay of wound healing (Goto et al., 2006, Ishikawa
et al., 2010).
Because EPPK is a plakin protein, we speculated that EPPK
might also be a PNP autoantigen. In this study, we investi-
gated whether anti-EPPK antibodies were present in PNP sera
by various analyses. Immunoprecipitation-immunoblotting
(IP-IB) detected anti-EPPK autoantibodies in 35 of 48 PNPFigure 1. EPPK detection in normal human skin and KU-8 cells. (a, b) IHC of nor
human skin (c, d), KU-8 cells (e, f), and rat bladder (g, h). Bars ¼ 50 mm. (i) IP-IB o
PNP (lanes 3e19), PV (lanes 20, 21), PF (lanes 22, 23), BP (lanes 24, 25), and nor
the 250-kDa molecular marker are shown on the left. (jel) Statistical analyses for
indicate statistically significant differences between EPPK(þ) PNP and EPPK() P
desmoglein; EPPK, epiplakin; IF, immunofluorescence; IHC, immunohistochemi
PNP, paraneoplastic pemphigus; PV, pemphigus vulgaris.
Journal of Investigative Dermatology (2016), Volume 136sera. Statistical analysis indicated correlations of anti-EPPK
antibodies with PNP-related BO and mortality. Additional
studies indicated that EPPK is expressed in respiratory cells
and tissues and was reacted by PNP sera, suggesting that anti-
EPPK autoantibodies may develop BO.
RESULTS
Clinical and immunological parameters for all 48 Japanese
patients with PNPare summarized in Supplementary Table S1
online.
Immunohistochemistry (IHC) and immunofluorescence (IF)
of normal human skin, KU-8 cells, and rat bladder
By IHC and IF of normal human skin, rabbit polyclonal
antibody (pAb) for human EPPK (anti-EPPK pAb) (Figure 1a
and c), but not normal rabbit IgG (Figure 1b and d), showed
cytoplasmic staining in entire epidermis. By IF, anti-EPPK pAb
(Figure 1e), but not normal rabbit IgG (Figure 1f), showed
perinuclear cytoplasmic staining in cultured KU-8 cells.
Finally, by IF using the rat bladder, anti-EPPK pAb (Figure 1g),
but not normal rabbit IgG (Figure 1h), showed cell surface
and cytoplasmic reactivity.
IB of normal human epidermal extract
We first attempted to detect anti-EPPK antibodies in 48
Japanese PNP sera by IB of normal human epidermal extract.
Anti-EPPK pAb detected approximately 500-kDa EPPK
(Supplementary Figure S1 online). However, whereas all PNP
sera detected the 210-kDa EPL and 190-kDa PPL, neither
PNP nor normal sera reacted with EPPK.mal human skin with anti-EPPK pAb and normal rabbit IgG. (ceh) IF of normal
f KU-8 cell extract for EPPK with anti-EPPK pAb (lane 1), no antibody (lane 2),
mal sera (lanes 26e29). The positions of the approximately 500-kDa EPPK and
association of BO (j), mortality (k), and ELISA indices for Dsg3 (l). Asterisks (*)
NP (P < 0.05). BO, bronchiolitis obliterans; BP, bullous pemphigoid; Dsg,
stry; IP-IB immunoprecipitation-immunoblotting; pAb, polyclonal antibody;
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EPPK Is PNP Autoantigen and Related to BOAbsorption analysis of anti-EPPK pAb with EPPK
recombinant protein (RP)
In IB of normal human epidermal extract, anti-EPPK pAb also
reacted with many lower molecular weight protein bands,
which may be other molecules or degraded EPPK fragments.
To confirm the specificity of anti-EPPK pAb, we performed
absorption analysis using human EPPK RP (Supplementary
Figure S2a online). Both intact EPPK and additional lower
protein bands seen before absorption were significantly
reduced by absorption with 0.3 mg EPPK RP, and completely
disappeared with 0.6 and 1.2 mg EPPK RP. The reduction of
EPPK reactivity was not seen by absorption with 5 and 10 mg
of total protein in lysate of Escherichia coli transformed with
the pGEX empty vector.
IB of KU-8 cell extract
Because we confirmed strong expression of EPPK in KU-8
cells by IF, we then tried to detect anti-EPPK antibodies in
PNP sera by IB using KU-8 cell extract. Anti-EPPK pAb
strongly reacted with the approximately 500-kDa EPPK, as
well as additional lower bands (Supplementary Figure S3
online). However, none of the representative PNP sera
reacted with EPPK, although all sera reacted with EPL and
PPL. No normal sera reacted with any plakin proteins.
IP-IB of KU-8 cell extract
To overcome the difficulty in detection of EPPK by IB ana-
lyses, we performed IP-IB of KU-8 cell extract (Figure 1i for
representative sera, and Supplementary Figure S4 online for
all sera). Nineteen PNP sera and anti-EPPK pAb reacted
strongly and exclusively with the approximately 500-kDa
EPPK, 16 PNP sera showed relatively weak but clear reac-
tivity with EPPK, and 13 PNP sera showed no reactivity. Thus,
35 (72.9%) of 48 PNP sera reacted with EPPK. This EPPK
band was not detected by 20 pemphigus vulgaris and 20
pemphigus foliaceus sera, but was very weakly detected by
one of 20 BP and two of 35 normal sera (Supplementary
Figure S4).
We also performed this IP-IB for additional 22 European
PNP sera. Eight sera reacted strongly and exclusively with
EPPK, and four sera reacted relatively weakly with EPPK
(Supplementary Figure S5 and Table S2 online). Thus, Euro-
pean PNP sera also clearly and frequently reacted with EPPK.
IP-IB of KU-8 cell extract preabsorbed with anti-EPPK pAb
To further confirm the specific reactivity of PNP sera with
EPPK, we performed IP-IB using KU-8 cell extract, which was
preabsorbed with anti EPPK pAb. In this IP-IB, two selected
PNP sera reacted with EPPK in non-preabsorbed KU-8 cell
extract, but not in KU-8 cell extract preabsorbed with anti-
EPPK pAb (Supplementary Figure S6 online).
Combined IP-IB of IP with anti-EPPK pAb and IB with
antibodies specific to various plakin family proteins
To further confirm the lack of cross-reactivity with the anti-
EPPK pAb with other plakin proteins, after IP of KU-8
extract with anti-EPPK pAb, immunoprecipitated proteins
were immunoblotted with antibodies specific to various
plakin proteins. As expected, EPPK was detected strongly in
both KU-8 extracts and immunoprecipitates (Supplementary
Figure S7a online). EPL and PPL were detected in KU-8
extracts but not in immunoprecipitates. Plectin anddesmoplakin were not detected in both extracts of KU-8 cells
and immunoprecipitated samples, suggesting that antibodies
to these plakins were not suitable for IB. Nevertheless, the
results for EPL and PPL strongly indicated that anti-EPPK pAb
had no cross-reactivity with other plakins.
IF of mouse skin and lung
To further demonstrate the specificity of anti-EPPK pAb and
antiemouse-EPPK pAb, we performed IF of skin and lung
tissues of wild-type and Eppk-knockout mice using these
pAbs. Both pAbs reacted with wild-type mouse tissues, but
no positive reactivity was observed in Eppk-knockout mouse
tissues (Supplementary Figure S7b and c). These results
indicated that both pAbs were specific to EPPK in mouse
tissues, and had no cross-reactivity with other plakins.
IB of purified EPPK RP
We also performed IB of EPPK RP for 48 PNP sera. Both anti-
GST monoclonal antibody and anti-EPPK pAb reacted
strongly with the 80-kDa EPPK RP, as well as additional lower
bands that were considered degradation products
(Supplementary Figure S8 online). The EPPK RP was also
recognized weakly by almost all PNP sera, including sera
negative for EPPK in IP-IB. None of control pemphigus vul-
garis, pemphigus foliaceus, BP, and normal sera reacted with
the RP.
Statistical analysis between clinical and immunological
features and EPPK reactivity in 48 Japanese patients with
PNP
We designated 35 EPPK-positive Japanese PNP cases and 13
EPPK-negative PNP cases in IP-IB as EPPK(þ) PNP and
EPPK() PNP, respectively. Relevant results in statistical an-
alyses are graphically shown (Figure 1jel). EPPK(þ) PNP
showed significantly higher frequency of BO than EPPK(e)
PNP (P ¼ 0.0303), and none of the 13 patients with EPPK()
PNP had BO (Figure 1j). Mortality was significantly higher in
EPPK(þ) PNP (P ¼ 0.0341) (Figure 1k). Dsg3 indices in
EPPK(þ) PNP (71.47  66.93) were significantly lower than
EPPK() PNP (116.57  90.80) (P ¼ 0.0333) (Figure 1l). The
results of other parameters showed no statistical significance
between EPPK(þ) PNP and EPPK() PNP (Table 1).
We also obtained information of BO in 17 of 22 European
patients with PNP (Supplementary Table S2).However, there
was no significant relationship between anti-EPPK antibodies
and BO in European patients with PNP (Mann-Whitney
U-test; P ¼ 0.297).
IHC and IF of normal human lung tissue and cultured lung
cells
Because statistical analyses showed a clear relationship be-
tween EPPK(þ) PNP and BO, we then examined whether
EPPK is present in lung tissues and respiratory cells. By IHC
and IF of normal human lung samples obtained from three
unrelated subjects, anti-EPPK pAb reacted relatively weakly
with alveolus cells (Figure 2a and c) and strongly with
bronchiole epithelia (Figure 2a, b, d, and e). Particularly,
granular staining was observed inside bronchiole epithelial
cells (Figure 2e, arrows). Normal rabbit IgG did not react with
these cells (Figure 2g, h, i, j, and k).
By IF of cultured normal human small airway epithelial
(NHSAE) cells, anti-EPPK pAb showed perinuclearwww.jidonline.org 401
Table 1. Results of clinical and immunological features in 48 patients with PNP and differences between EPPK(D)
PNP and EPPK(L) PNP, which were not statistically significant (P > 0.05), except for BO (P [ 0.0303)
Parameters (n [ cases with description) EPPK(D) PNP EPPK(L) PNP Total
Age (n ¼ 46) 59.09  11.97 53.77  13.48 57.59  12.49
Gender (n ¼ 47)
Females 24/34 (70.6%) 9/13 (69.2%) 33/47
Males 10/34 (29.4%) 4/13 (30.8%) 14/47
Cutaneous lesions
Trunk (n ¼ 44) 20/33 (60.6%) 9/11 (81.8%) 29/44
Extremities (n ¼ 44) 18/33 (54.5%) 5/11 (45.5%) 23/44
Mucous lesions
Oral (n ¼ 44) 33/33 (100.0%) 11/11 (100.0%) 44/44
Ocular (n ¼ 39) 16/28 (57.1%) 8/11 (72.7%) 24/39
Nasal (n ¼ 39) 8/28 (28.6%) 2/11 (18.2%) 10/39
Genital (n ¼ 37) 10/27 (37.0%) 6/10 (60.0%) 16/37
BO (n ¼ 48) 10/35 (28.6%) 0/13 (0%) 10/48
Acantholysis (n ¼ 39) 14/29 (48.3%) 8/10 (80.0%) 22/39
Necrotic cells (n ¼ 39) 9/29 (31.0%) 5/10 (50.0%) 14/39
Liquefaction degeneration (n ¼ 39) 5/29 (17.2%) 1/10 (10.0%) 6/39
Reactivity for therapy (n ¼ 43) 13/31 (41.9%) 9/12 (75.0%) 22/43
Rat bladder indirect IF (n ¼ 48) 27/35 (77.1%) 9/13 (69.2%) 36/48
Human skin indirect IF (n ¼ 48) 22/35 (62.9%) 11/13 (84.6%) 33/48
Dsg1 (n ¼ 48) 23.94  40.28 14.98  20.38 21.51  36.00
Abbreviations: BO, bronchiolitis obliterans; Dsg, desmoglein; EPPK, epiplakin; IF, immunofluorescence; PNP, paraneoplastic pemphigus.
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402cytoplasmic staining (Figure 2f), similar to that seen in KU-8
cells (Figure 1e). Normal rabbit IgG showed no staining
(Figure 2l).
IB of NHSAE cell extract
By IB of NHSAE cell extract, anti-EPPK pAb reacted strongly
with the approximately 500-kDa EPPK, as well as smear-like
additional lower bands (Figure 3a). However, none of
representative PNP sera with or without BO showed the
reactivity with EPPK (Figure 3a). PNP sera reacted with PPL
but not EPL. Normal sera reacted with no plakin protein in
NHSAE cell extract.
Interestingly, whereas KU-8 cell extract showed only one
EPPK protein band (K-EPPK for keratinocyte-EPPK), NHSAE
cell extract showed two different EPPK bands, K-EPPK and L-
EPPK (for lung-EPPK), with weaker reactivity with L-EPPK
(Figure 3b).
IP-IB of NHSAE cell extract
We next performed IP-IB of NHSAE cell extract for repre-
sentative BO(þ) and BO() PNP sera (Figure 3c). Anti-EPPK
pAb reacted with doublet bands of the approximately 500-
kDa EPPK, with stronger reactivity with the lower band (K-
EPPK) and weaker reactivity with the upper band (L-EPPK).
Some of both BO(þ) and BO() PNP sera reacted with the
doublet EPPK bands in the same pattern. No normal sera
showed this reactivity.
Injection of rabbit antiemouse-EPPK pAb into mice
To further investigate whether EPPK relates to BO, we per-
formed injection experiments of antiemouse-EPPK pAb into
mice. In our preliminary study, the antiemouse-EPPK pAb
reacted with the approximately 700-kDa mouse EPPK by IB
of mouse skin extract, and the reactivity reduced significantlyJournal of Investigative Dermatology (2016), Volume 136by preabsorption with mouse EPPK RP (Supplementary
Figure S2b), confirming the specific reactivity with EPPK.
In injection experiments, to exclude the nonspecific effect
of normal IgG injection, we first injected normal rabbit IgG at
doses of 0 (control), 1, 2, 4, and 6 mg (n ¼ 3) into BALB/c
mice, and bred for 2 weeks. Histopathologically, no
abnormal morphological changes were found in both skin
and lung tissues taken from the mice (Supplementary
Figure S9 online).
In preliminary IF of skin and lung tissues from noninjected
mice, antiemouse-EPPK pAb clearly stained entire epidermis
and bronchiole epithelia, respectively (Figure 4a).
In mice injected with antiemouse-EPPK pAb, direct IF of
skin and lung tissues using FITC-conjugated anti-rabbit IgG
showed positive staining of entire epidermis and bronchiole
epithelia, respectively (Figure 4b), indicating that injected
antiemouse-EPPK pAb actually penetrated into skin and lung
cells.
In mice injected with antiemouse-EPPK pAb, the histo-
pathological study showed no obvious abnormality in skin
(Figure 4c). In contrast, lung showed mononuclear cell
infiltration and extracellular matrix deposition in peribron-
chial areas, as well as detached epithelial cells, suggesting
loss of cell-cell adhesion (Figure 4c). No significant change
was observed in lung tissue from mice injected with normal
rabbit IgG.DISCUSSION
In this study, we first showed that none of 48 Japanese PNP
sera reacted with EPPK by IB of both normal human
epidermal extract and cultured KU-8 cell extract, probably
due to loss of conformation of EPPK during IB procedure.
Then, we performed IP-IB of KU-8 cell extract, which
Figure 2. IHC and IF of normal
human lung tissue and NHSAE cells.
(a, b, g, h) IHC of normal human lung
tissue with anti-EPPK pAb and normal
rabbit IgG. (cef, iel) IF of normal
human lung tissue (c, i: alveolus, d, e,
j, i: bronchial epithelia) and NHSAE
cells (f, l) with anti-EPPK pAb and




normal human small airway
epithelial; pAb, polyclonal antibody.
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EPPK Is PNP Autoantigen and Related to BOsuccessfully detected anti-EPPK antibodies in 35 (72.9%) of
48 PNP sera. By IHC and IF, anti-EPPK pAb showed clearly
positive reactivity in both normal human skin and rat bladder,
suggesting high and wide expression of EPPK in various
epithelia.
Our statistical analysis revealed that BO was significantly
more prevalent in EPPK(þ) PNP than EPPK() PNP. Severalmechanisms for PNP-related BO were proposed (Nousari
et al., 1999; Takahashi et al., 2000). Airway mucosa in pa-
tients with PNP with BO showed acantholysis and IgG
deposition in bronchial epithelium, suggesting that
autoantibody-mediated acantholytic process occurred in
respiratory tissues. However, because bronchial epithelia
express only Dsg2, anti-Dsg1 and Dsg3 autoantibodies inwww.jidonline.org 403
Figure 3. IB and IP-IB of NHSAE cell
extract. (a) IB of NHSAE cell extract
with anti-EPPK pAb (lane 1), BO()
PNP (lanes 2e4), BO(þ) PNP (lanes
5e7), and normal sera (lanes 8e10).
(b) Comparative IB study of KU-8 cell
and NHSAE cell extracts with anti-
EPPK pAb. The positions of molecular
markers are shown on the left (a, b).
The positions of EPPK, EPL, and PPL
(a) and those of K-EPPK and L-EPPK
(b) are shown on the right. (c) IP-IB
of NHSAE cell extract with anti-EPPK
pAb (lane 1), no antibody (lane 2),
BO(e) PNP (lanes 3e10), BO(þ) PNP
(lanes 11e18), and normal sera (lanes
19e24). Red numbers indicate lanes
with positive reactivity with EPPK.
BO, bronchiolitis obliterans; BP,
bullous pemphigoid; Dsg,





human small airway epithelial; pAb,
polyclonal antibody; PNP,
paraneoplastic pemphigus; PPL,
periplakin; PV, pemphigus vulgaris.
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404PNP sera should not contribute to this change. In contrast,
respiratory epithelium expresses various plakin proteins
including EPPK. Therefore, we speculated that anti-EPPK
antibodies in PNP sera may react with EPPK in lung tissues
and cause BO.
To confirm this speculation, we first showed that EPPK was
present in normal lung tissue and NHSAE cells by IHC and IF
using anti-EPPK pAb. EPPK expressed strongly in bronchiole
epithelia and weakly in alveolar cells. IB also confirmed
expression of EPPK in NHSAE cells. Similar to IB of epidermal
extract or KU-8 cell extract, no PNP sera recognized EPPK in
IB of NHSAE cell extract. In contrast, in IP-IB of NHSAE cell
extract, most sera from patients with BO(þ) PNP and patients
with BO() PNP reacted with both L-EPPK (weakly) and
K-EPPK (strongly). This positive reactivity of PNP sera with
EPPK in lung cells further suggested that anti-EPPK autoan-
tibodies cause BO. However, the result that both BO(þ) PNP
and BO() PNP reacted with EPPK in NHSAE cells made the
pathogenic role of EPPK in the development of BO obscure.
To further unravel the pathogenic role of EPPK in BO
development, we injected antiemouse-EPPK pAb into mice.
IF indicated that the injected antiemouse-EPPK pAb could
penetrate into the skin and lung cells of mice. Histopathology
revealed abnormal changes in lung tissue, but not in skin.
These results further indicated that anti-EPPK antibodies can
develop BO. Similar abnormal histopathological features
were also shown in CXCL10 transgenic mice with BO-like
inflammation (Jiang et al., 2012).Journal of Investigative Dermatology (2016), Volume 136However, other mechanisms in the development of BO
were also proposed. Proinflammatory cytokines and che-
mokines and growth factors were secreted from epithelial
cells or T cells during BO development (Boehler et al., 2003).
In a recent study, Dsg3 expression in lung was observed in a
PNP mouse model using Dsg3-target mice and naphthalene
treatment (Hata et al., 2013). Pten knockout mice showed
lung fibrosis with upregulation of snail and downregulation
of E-cadherin and tight junction proteins (Miyoshi et al.,
2013). Therefore, these other factors and anti-EPPK anti-
bodies may coordinately develop BO.
The mechanism by which injected pAb accessed intra-
cytoplasmic EPPK in skin and lung was currently unclear.
However, the penetration of autoantibodies into living cellswas
reported for antinuclear antibodies in systemic lupus erythe-
matosus (Rekviget al., 2012;Toubi andShoenfeld, 2007) and for
antimelanocyte antibodies in vitiligo (Ruiz-Argu¨elles et al.,
2007). Similarmechanismsmayoccur for anti- EPPKantibodies.
In contrast to lung, abnormal morphology was not found in
the skin of mice injected with antiemouse-EPPK pAb. EPPK
knockout mice did not show abnormal epidermis or hair
(Goto et al., 2006). These findings may indicate that EPPK is
not essential in the development and structural integrity of
skin.
European patients with PNP were reported to show lower
incidence of BO development and lower mortality
(Leger et al., 2012). Therefore, we also performed IP-IB for
European PNP sera and found that 54.5% of the sera reacted
Figure 4. Injection experiments of antiemouse-EPPK pAb into mice. (a)
Results of IF of skin and lung tissue from noninjected mice using antiemouse-
EPPK pAb. (b) Results of direct IF of skin and lung tissue from mice injected
with antiemouse-EPPK pAb or normal rabbit IgG using FITC-conjugated anti-
rabbit IgG without the first antibody (no 1st Ab). (c) Histopathological findings
of skin and lung tissue from mice injected with antiemouse-EPPK pAb or
normal rabbit IgG (hematoxylin and eosin staining). Bars ¼ 100 mm. EPPK,
epiplakin; IF, immunofluorescence; pAb, polyclonal antibody.
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in PNP sera across racial lines. However, there was no sig-
nificant relationship between anti-EPPK antibodies and BO
in European PNP. The different results between Japanese
patients with PNP and European patients with PNP might be
caused by different genetic background, including HLA,
although a small cohort for European PNP in our study may
also explain the difference.
This study indicated the presence of two different EPPK
proteins, that is, smaller K-EPPK and larger L-EPPK.
Epidermal KU-8 cells expressed only K-EPPK, whereas res-
piratory NHSAE cells expressed both K-EPPK and L-EPPK.
EPPK has phosphorylation sites, but no glycosylation sites
(Dephous et al., 2008; Olsen et al., 2006; Yu et al., 2007).
However, different phosphorylation cannot explain the dif-
ference in migration in the huge 500-kDa protein on SDS-
PAGE. Thus, the different sizes in EPPK may be due to
protein truncation by alternative splicing or proteolysis.
A recent IB study of A549 cell extract suggested the pres-
ence of anti-PPL autoantibodies in idiopathic pulmonary
fibrosis (Taille et al., 2011), suggesting that autoantibodies to
plakin proteins cause various inflammatory lung diseases. We
also performed preliminary studies using A549 cells. How-
ever, A549 cells did not express EPPK (data not shown). This
may be explained by the fact that A549 cells originated from
human adenocarcinoma of alveolar basal epithelial cells
(Giard et al., 1973), which expressed a very low level of
EPPK. Our IB of NHSAE cells detected PPL but not EPL,
whereas a previous IP study of normal human bronchiole
epithelial cells detected all desmoplakin, PPL and EPL
(Nousari et al., 1999). These results indicate that different
respiratory cells may express plakins in different patterns.
Therefore, it may also be possible to speculate that anti-EPPK
autoantibodies cause idiopathic pulmonary fibrosis.
Statistic analyses also indicated that EPPK(þ) PNP showed
a lower level of anti-Dsg3 antibodies. Anti-Dsg3 antibodies
are pathogenic in a mouse model for both pemphigus vul-
garis (Amagai, 1996; Amagai et al., 1991) and PNP (Amagai
et al., 1998). Thus, the lower level of anti-Dsg3 antibodies
generally means lower disease activity. However, in our
study, EPPK(þ) PNP cases with lower anti-Dsg3 autoanti-
bodies actually showed higher mortality, indicating that anti-
EPPK antibodies may cause fatal outcome.
Intriguing issue in this study was the possibility of the cross
reactivity of anti-EPPK antibodies among various plakin
family proteins. EPPK has a unique structure with many
repeats of plakin-specific B-domain and linker-domain,
which are also present in C-terminal regions of other
plakin proteins, except for PPL (Supplementary Figure S10a
online). Indeed, amino acid sequence alignment revealed an
identical domain of eight amino acid residues in B-domains
in all plakin proteins, except for PPL (Supplementary
Figure S10b).
In our IB studies, pAbs to both human and mouse-EPPKs
showed additional smaller protein bands, which might be
other plakin proteins. However, preabsorption of pAbs with
human and mouse EPPK RPs abolished reactivity with all
protein bands, indicating that the lower proteins were
degradation products of EPPK and both pAbs were specific to
EPPK.www.jidonline.org 405
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9th B-domains and between 15th and 16th B-domains, which
were used to prepare pAbs to human and mouse EPPKs,
respectively, among various human and mouse plakin pro-
teins (Supplementary Table S3 online). For both the linker
regions, homology between human and mouse EPPKs was
more than 50%, whereas homologies between EPPK and
other plakin proteins were very low. This result also suggested
that both pAbs should be specific to EPPK.
Furthermore, our combined IP-IB using antibodies specific
to various plakins for IB indicated that samples immunopre-
cipitated by anti-EPPK pAb had only EPPK, but not other
plakins, in KU-8 cell extract. In addition, anti-EPPK pAbs
reacted clearly with lung and skin tissues of wild-type mouse,
but no reactivity was observed in Eppk-knockout mouse.
These results convincingly confirmed that pAbs to both hu-
man and mouse EPPKs did not cross-react with other plakin
proteins.
However, we could not exclude completely the possibility
that anti-EPPK autoantibodies in PNP sera might cross-react
with other plakin proteins. Indeed, the positive reactivity of
all PNP sera with EPPK RP might be due to cross-reactivity
with other plakin proteins.
Nevertheless, we convincingly confirmed that sera from
patients with PNP reacted clearly and specifically with EPPK
in our IP-IB of KU-8 cell extract, which strongly suggested
that sera from patients with PNP had autoantibodies to
EPPK. In addition, statistical analyses strongly indicated that
EPPK was related to BO development. These results
adequately indicated that autoantibodies, which have spe-
cific or stronger reactivity with EPPK, were present in the
majority of the PNP sera, and may cause BO in particular
patients.
In conclusion, this study showed that EPPK is one of PNP
autoantigens, and the presence of anti-EPPK antibodies is
significantly related to the development of BO and higher
mortality. Abnormal histopathological changes were found in
lung tissues in mice injected with anti-EPPK pAb, indicating a
pathogenic role of anti-EPPK antibodies in the development
of BO. Therefore, detection of anti-EPPK antibodies may lead
to more extensive treatments to avoid the development of
fatal PNP-related BO.
MATERIALS AND METHODS
All studies followed guidelines of Medical Ethics Committees of
Kurume University School of Medicine, and were conducted ac-
cording to Declaration of Helsinki principles. Informed consents
were written by all patients and control individuals.
Materials
All chemicals used for biochemical analyses were of analytical
grade and were purchased from Sigma-Aldrich (St. Louis, MO)
or Nacalai Tesque (Kyoto, Japan). Details for preparation of
anti-EPPK pAb and antiemouse-EPPK pAb are described in
Supplementary Materials and Methods online. Horseradish peroxi-
dase-conjugated goat antibodies to human IgG, rabbit IgG, or mouse
IgG for second antibodies in IB were obtained from Dako (Glostrup,
Denmark).
This study used 48 PNP sera that were collected between 1997
and 2007 at the Department of Dermatology, Kurume UniversityJournal of Investigative Dermatology (2016), Volume 136School of Medicine. Three PNP cases were treated in Kurume
University Hospital and the rest were sent from other institutes. All
patients with PNP showed typical clinical, histopathological, and
immunopathological features. All 48 PNP sera reacted with the 210-
kDa EPL and 190-kDa PPL by IB using normal human epidermal
extract (Hashimoto, 2001). We also obtained 22 sera from European
patients with PNP (16 from the Netherlands, 4 from Germany,
and 1 each from Poland and Hungary). Sera were obtained from
20 patients each with pemphigus vulgaris, pemphigus foliaceus and
BP as disease controls, and from 35 healthy volunteers as normal
controls. All sera were stored at 30 C or 80 C, and aliquots with
0.1% sodium azide as a preservative were kept at 4 C during
experiments.
BALB/c adult mice (5-week-old) were purchased from Kyudo
(Tosu, Japan). All operations with mice (breeding, antiemouse-EPPK
pAb injection and tissue collection) were ordered to Kyudo.
Preparation of human and mouse EPPK RPs and pAbs to
them
Technical details are described in Supplementary Materials and
Methods.
IHC and IF for EPPK
We performed IHC or IF of normal human skin and lung tissue, as
well as KU-8 cells and NHSAE cells, using anti-EPPK pAbs. We also
performed IF of skin and lung tissue taken from wild-type and Eppk-
knockout mice. Technical details are described in Supplementary
Materials and Methods.
IB of normal human epidermal extract, extracts of KU-8 cells
and NHSAE cells, and human EPPK RP
We performed IB analyses of various substrates for detecting EPPK.
Technical details are described in Supplementary Materials and
Methods.
Adsorption of anti-EPPK pAb and antiemouse-EPPK pAb
with EPPK RPs
To confirm the specificity of anti-EPPK pAb or antiemouse-
EPPK pAb, we performed adsorption analysis using EPPK RPs.
Technical details are described in Supplementary Materials and
Methods.
IP-IB of KU-8 cell and NHSAE cell extracts
Technical details are described in Supplementary Materials and
Methods.
IP-IB for PNP sera using KU-8 cell extract preabsorbed with
anti-EPPK pAb, and combined IP-IB using antibodies specific
to various plakin family proteins
Technical details are described in Supplementary Materials and
Methods.
Injection experiments of antiemouse-EPPK pAb injection
into mice
Technical details are described in Supplementary Materials and
Methods.
Dsg1 and Dsg3 ELISAs
ELISAs for Dsg1 and Dsg3 were performed according to standard
procedures (MBL, Nagoya, Japan) (Billet et al., 2006).
Statistical analysis
Differences among qualitative results were statistically compared
using the chi-square test and Bonferoni adjustment. Differences
in quantitative parameters among different groups were assessed
A Tsuchisaka et al.
EPPK Is PNP Autoantigen and Related to BOusing the Mann-Whitney test. All data are expressed as means 
standard deviation. All analyses were performed using SPSS (SPSS,
Chicago, IL).
Amino acid sequence alignment of plakin family proteins
Multiple sequence alignment of plakin family was made with
ClustalW (www.genome.jp/tools/clustalw) and MacBoxshade
version 2.15 (Institute for Animal Health, Woking, UK).
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